166 related articles for article (PubMed ID: 33567928)
1. Comparative efficacy assessment of antiviral alone and antiviral-antibiotic combination in prevention of influenza-B infection associated complications.
Ishaqui A; Hayat Khan A; Sulaiman SAS; Taher Alsultan M; Khan I
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1165-1173. PubMed ID: 33567928
[TBL] [Abstract][Full Text] [Related]
2. Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients.
Ishaqui AA; Khan AH; Sulaiman SA; Alsultan M; Khan I
Saudi Med J; 2020 Sep; 41(9):1015-1021. PubMed ID: 32893285
[TBL] [Abstract][Full Text] [Related]
3. Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief.
Ishaqui AA; Khan AH; Sulaiman SAS; Alsultan MT; Khan I; Naqvi AA
Expert Rev Respir Med; 2020 May; 14(5):533-541. PubMed ID: 32053044
[No Abstract] [Full Text] [Related]
4. Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.
Ishaqui AA; Khan AH; Syed Sulaiman SA; Alsultan M; Khan I
Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1763-1770. PubMed ID: 33612459
[TBL] [Abstract][Full Text] [Related]
5. Assessment of antiviral and antibiotic combination treatment in influenza-A H1N1 induced acute kidney injury among hospitalized patients.
Ishaqui AA; Khan AH; Syed Sulaiman SA; Alsultan MT; Khan I; Al Nami H
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1225-1233. PubMed ID: 31303595
[TBL] [Abstract][Full Text] [Related]
6. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.
Lee N; Hui DS; Zuo Z; Ngai KL; Lui GC; Wo SK; Tam WW; Chan MC; Wong BC; Wong RY; Choi KW; Sin WW; Lee EL; Tomlinson B; Hayden FG; Chan PK
Clin Infect Dis; 2013 Dec; 57(11):1511-9. PubMed ID: 24046309
[TBL] [Abstract][Full Text] [Related]
7. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of clarithromycin-naproxen-oseltamivir combination therapy versus oseltamivir alone in hospitalized pediatric influenza patients.
Lee CW; Tai YL; Huang LM; Chi H; Huang FY; Chiu NC; Huang CY; Tu YH; Wang JY; Huang DT
J Microbiol Immunol Infect; 2021 Oct; 54(5):876-884. PubMed ID: 32978076
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hospitalization among children with influenza B infection.
Moolasart V; Manosuthi W
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):622-9. PubMed ID: 24974646
[TBL] [Abstract][Full Text] [Related]
11. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
Kim WY; Young Suh G; Huh JW; Kim SH; Kim MJ; Kim YS; Kim HR; Ryu YJ; Han MS; Ko YG; Chon GR; Lee KH; Choi SH; Hong SB;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5703-9. PubMed ID: 21968371
[TBL] [Abstract][Full Text] [Related]
12. Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests.
Au Yeung V; Thapa K; Rawlinson W; Georgiou A; Post JJ; Overton K
BMC Infect Dis; 2021 Apr; 21(1):321. PubMed ID: 33827458
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Hung IFN; To KKW; Chan JFW; Cheng VCC; Liu KSH; Tam A; Chan TC; Zhang AJ; Li P; Wong TL; Zhang R; Cheung MKS; Leung W; Lau JYN; Fok M; Chen H; Chan KH; Yuen KY
Chest; 2017 May; 151(5):1069-1080. PubMed ID: 27884765
[TBL] [Abstract][Full Text] [Related]
14. The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza.
Lim JK; Kim TH; Kilgore PE; Aiello AE; Choi BM; Lee KC; Yoo KH; Song YH; Kim YK
J Korean Med Sci; 2014 Apr; 29(4):485-93. PubMed ID: 24753694
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with early hospital discharge of adult influenza patients.
Lee N; Chan PK; Choi KW; Lui G; Wong B; Cockram CS; Hui DS; Lai R; Tang JW; Sung JJ
Antivir Ther; 2007; 12(4):501-8. PubMed ID: 17668558
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
Orzeck EA; Shi N; Blumentals WA
Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections.
Ramirez J; Peyrani P; Wiemken T; Chaves SS; Fry AM
Clin Infect Dis; 2018 Aug; 67(5):736-742. PubMed ID: 29659754
[TBL] [Abstract][Full Text] [Related]
18. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
Kang SJ; Park KH; Kee SJ; Shin JH; Jung SI; Kwon YS; Jang HC
Jpn J Infect Dis; 2013; 66(5):425-7. PubMed ID: 24047743
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
20. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F
Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]